Stay updated on Ecztra 4: Tralokinumab Drug Interaction Clinical Trial
Sign up to get notified when there's something new on the Ecztra 4: Tralokinumab Drug Interaction Clinical Trial page.

Latest updates to the Ecztra 4: Tralokinumab Drug Interaction Clinical Trial page
- CheckyesterdayChange DetectedA minor site revision updated the page to include Revision: v3.3.4 and remove Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now consolidates site information under a general Locations heading, listing Arkansas, California, Florida, Massachusetts, South Carolina, and Virginia. Per-state location sections were removed, and the page revision updated to v3.3.3.SummaryDifference0.7%

- Check51 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedRemoved the temporary notice about government funding and NIH operating status from the page.SummaryDifference0.3%

- Check81 days agoChange DetectedThese changes are minor UI updates and metadata changes that do not modify the study's core details. There were no changes to eligibility criteria, interventions, primary outcomes, or location lists.SummaryDifference0.4%

- Check102 days agoChange DetectedUpdated operating status notice and new version (v3.2.0) replacing the old v3.1.0. The page now informs users about potential delays and non-processing of transactions due to funding lapses, and points to official sites for status updates.SummaryDifference4%

Stay in the know with updates to Ecztra 4: Tralokinumab Drug Interaction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ecztra 4: Tralokinumab Drug Interaction Clinical Trial page.